Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease

Abroad (travel likely)Recruiting

Conditions

Systemic Sclerosis · Interstitial Lung Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Central Hospital, Nancy, France
Contact: Study coordinator (Paul DECKER, MD) · decker.paul57130@gmail.com
Contact: Principal Investigator (Roland JAUSSAUD, Pr)

Study leads

Paul Decker, MD
Principal Investigator
Central Hospital, Nancy, France

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease

Systemic Sclerosis Associated Interstitial Lung Disease · Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD) · Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Wuhan, China

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

Interstitial Lung Disease with Progressive Fibrotic Phenotype in Diseases Classified Elsewhere · Systemic Sclerosis Pulmonary · Dermatomyositis

Abroad (travel likely)Recruiting

Oslo, Norway

ILD-SARDs Registry and Biorepository

Interstitial Lung Disease · Systemic Autoimmune Disease · Rheumatic Diseases

Abroad (travel likely)Recruiting

Montreal, Canada

A Phase 1/2 Study of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

Healthy Volunteers · Systemic Sclerosis (SSc) · Scleroderma, Systemic

Abroad (travel likely)RecruitingPHASE1, PHASE2

Melbourne, Australia · Beijing, China